Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NK

NantKwest (NK) Stock Price, News & Analysis

NantKwest logo

About NantKwest Stock (NASDAQ:NK)

Key Stats

Today's Range
$2.74
$2.91
50-Day Range
$16.09
$38.70
52-Week Range
$2.52
$45.42
Volume
10.72 million shs
Average Volume
1.57 million shs
Market Capitalization
$307.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantKwest and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NK Stock News Headlines

Alert: Prepare for Trump's Dollar Overhaul
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
Space Nk Promo Codes
See More Headlines

NK Stock Analysis - Frequently Asked Questions

NantKwest, Inc. (NASDAQ:NK) posted its earnings results on Monday, May, 11th. The biotechnology company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.02. The biotechnology company had revenue of $0.02 million for the quarter. NantKwest had a negative net margin of 76,658.58% and a negative trailing twelve-month return on equity of 56.06%.

NantKwest (NK) raised $150 million in an IPO on Tuesday, July 28th 2015. The company issued 7,000,000 shares at a price of $20.00-$23.00 per share. BofA Merrill Lynch, Citigroup, Jefferies and Piper Jaffray served as the underwriters for the IPO and MLV & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that NantKwest investors own include Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Dynavax Technologies (DVAX) and OPKO Health (OPK).

Company Calendar

Last Earnings
5/11/2020
Today
9/17/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:NK
CIK
1326110
Fax
N/A
Employees
160
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.79 million
Net Margins
-76,658.58%
Pretax Margin
N/A
Return on Equity
-56.06%
Return on Assets
-46.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.74
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
7,681.49
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.23 per share
Price / Book
2.28

Miscellaneous

Outstanding Shares
109,345,000
Free Float
N/A
Market Cap
$307.26 million
Optionable
Not Optionable
Beta
2.61
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:NK) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners